21479583

Source:http://linkedlifedata.com/resource/pubmed/id/21479583

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0017636, umls-concept:C0543467, umls-concept:C0557061, umls-concept:C0580836, umls-concept:C0677850, umls-concept:C0680226, umls-concept:C1554080, umls-concept:C1704769, umls-concept:C1706198, umls-concept:C2584313
pubmed:issue	6
pubmed:dateCreated	2011-5-23
pubmed:abstractText	This article discusses data from 3 randomized phase 3 trials, supporting a role for surgery in glioblastoma.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0151000
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Alkylating, http://linkedlifedata.com/resource/pubmed/chemical/Carmustine, http://linkedlifedata.com/resource/pubmed/chemical/Dacarbazine, http://linkedlifedata.com/resource/pubmed/chemical/temozolomide
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	0942-0940
pubmed:author	pubmed-author:StummerWalterW, pubmed-author:WestphalManfredM, pubmed-author:van den BentMartin JMJ
pubmed:issnType	Electronic
pubmed:volume	153
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1211-8
pubmed:meshHeading	pubmed-meshheading:21479583-Aged, pubmed-meshheading:21479583-Antineoplastic Agents, Alkylating, pubmed-meshheading:21479583-Brain Neoplasms, pubmed-meshheading:21479583-Carmustine, pubmed-meshheading:21479583-Chemotherapy, Adjuvant, pubmed-meshheading:21479583-Combined Modality Therapy, pubmed-meshheading:21479583-Cranial Irradiation, pubmed-meshheading:21479583-Dacarbazine, pubmed-meshheading:21479583-Dose Fractionation, pubmed-meshheading:21479583-Female, pubmed-meshheading:21479583-Follow-Up Studies, pubmed-meshheading:21479583-Glioblastoma, pubmed-meshheading:21479583-Humans, pubmed-meshheading:21479583-Male, pubmed-meshheading:21479583-Middle Aged, pubmed-meshheading:21479583-Prognosis, pubmed-meshheading:21479583-Proportional Hazards Models, pubmed-meshheading:21479583-Radiotherapy, Adjuvant, pubmed-meshheading:21479583-Randomized Controlled Trials as Topic, pubmed-meshheading:21479583-Survival Rate
pubmed:year	2011
pubmed:articleTitle	Cytoreductive surgery of glioblastoma as the key to successful adjuvant therapies: new arguments in an old discussion.
pubmed:affiliation	Department of Neurosurgery, University of Münster, Albert-Schweitzer-Str. 33, 48149, Münster, Germany. walter.stummer@ukmuenster.de
pubmed:publicationType	Journal Article, Comparative Study, Research Support, Non-U.S. Gov't